483 Patheon Biologics (NJ) Sep 2013

483 Patheon Biologics (NJ) Sep 2013

Barbara Wilimczyk-Macri FDA$119.00 - Available Now

FDA investigators audited the Patheon Biologics (NJ) - Princeton, NJ, United States facility and issued inspectional observations (via FDA 483) on 26 Sep 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 26 Sep 2013
  • Location: Princeton, United States
  • FEI: 3003976111
Add To Cart